213.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$211.83
Aprire:
$211.01
Volume 24 ore:
1.16M
Relative Volume:
0.68
Capitalizzazione di mercato:
$50.15B
Reddito:
$244.67B
Utile/perdita netta:
$1.68B
Rapporto P/E:
30.67
EPS:
6.9487
Flusso di cassa netto:
$5.51B
1 W Prestazione:
-1.25%
1M Prestazione:
-2.06%
6M Prestazione:
+39.04%
1 anno Prestazione:
+58.60%
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CAH
Cardinal Health Inc
|
213.10 | 49.85B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
MCK
Mckesson Corporation
|
867.34 | 105.76B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
322.37 | 61.78B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
HSIC
Henry Schein Inc
|
77.21 | 8.88B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
2.13 | 1.89B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
KBC Group NV Grows Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Singapore
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cardinal Health Inc. stock (US14149Y1082): Why does its distribution model matter more for investors - AD HOC NEWS
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings - Finviz
Cardinal Health Report: Expanding Advanced Therapies into Community Care - Intellectia AI
More advanced treatments are moving beyond hospitals and closer to home - Stock Titan
Evercore ISI Trims Cardinal Health (CAH) Target While Maintaining Bullish Rating - Yahoo Finance
Walton Hills warehouse used by Cardinal Health fetches nearly $40 million - Crain's Cleveland Business
Robeco Institutional Asset Management Trims Cardinal Health Holdings - National Today
Burney Co. Boosts Cardinal Health Stock Position by 27% - National Today
Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook - ADVFN
Cardinal Health Stock (CAH) Opinions on Geopolitical Sell-Off and Leadership Shift - Moomoo
Cardinal Health Tops Volume Charts With $280 Million Trade As Specialty Boom Drives Investor Reassessment - Bitget
How The Cardinal Health (CAH) Investment Story Is Shifting As Analysts Rework Their Models - Yahoo Finance
Expanded Actinium‑225 Capacity And Higher EPS Guidance Could Be A Game Changer For Cardinal Health (CAH) - Yahoo Finance
Charles River Labs stock: Margin Boost from Divestitures Signals Buy Opportunity - AD HOC NEWS
Charles River Labs stock: New Asia partnership signals growth potential - AD HOC NEWS
We Ran A Stock Scan For Earnings Growth And Cardinal Health (NYSE:CAH) Passed With Ease - Yahoo Finance
Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032 - GlobeNewswire Inc.
How Investors Are Reacting To Cardinal Health (CAH) Expanding Actinium-225 Capacity For Targeted Alpha Therapies - Sahm
Here’s Why Investing in Cardinal Health Shares Could Benefit Your Portfolio Right Now - Bitget
Cardinal Health (CAH) Gains But Lags Market: What You Should Know - Yahoo Finance Singapore
Cardinal Health Inc. stock rises Wednesday, still underperforms market - MarketWatch
CAH PE Ratio & Valuation, Is CAH Overvalued - Intellectia AI
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now - Yahoo Finance
Evercore Maintains Cardinal Health(CAH.US) With Buy Rating, Cuts Target Price to $240 - Moomoo
Cardinal Health Faces "Beat and Raise" Test as Raised Guidance Becomes New Baseline - Bitget
Is Cardinal Health (CAH) Stock Undervalued Right Now? - Yahoo Finance
A Look At Cardinal Health (CAH) Valuation After Expanded Actinium-225 Cancer Therapy Production - Sahm
Cardinal Health, Inc. (CAH) stock price, news, quote and history - Yahoo Finance UK
Longtime supervisor sues Cardinal Health over age and gender bias - hcamag.com
Cardinal Health, Inc. (CAH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cardinal Health ER Laceration Tray ACS-SLAC1 | Health Supply 770 INC - primetimes.id
Assessing Cardinal Health (CAH) Valuation After Its Recent Share Price Move - Yahoo Finance
Cardinal Health (NYSE:CAH) Upgraded at Wall Street Zen - MarketBeat
Global Clinical Drainage Supplies Market Dominated by North America as Cardinal Health and Medline Expand Products - Carroll County Mirror-Democrat
Wells Fargo raises outlook on Cardinal Health (CAH), cites broad business strength - MSN
Tema Etfs LLC Trims Cardinal Health Stock Position - National Today
Tema Etfs LLC Decreases Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Inc (CLH.SG) stock price, news, quote and history - Yahoo Finance UK
Cardinal Health Increases Ac-225 Production to Enhance Cancer Treatment Options - Bitget
Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies - Yahoo Finance
HF Advisory Group LLC Buys 5,049 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Kwmg LLC Has $16.51 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts - Yahoo Finance
Cardinal Health expands Actinium-225 production capacity to supp - GuruFocus
Cardinal Health, Shine Technologies amp up domestic production of radiopharmaceuticals - Healthcare Brew
Cardinal Health (CAH) Boosts Actinium-225 Production for Future Therapies - GuruFocus
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth? - The Globe and Mail
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):